Stock Split Archives - Page 12 of 39

1 minute read

PaxMedica Announces 1-For-17 Reverse Stock Split

October 30, 11:30 AM

PaxMedica, Inc. (NASDAQ:PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (APT) for the treatment of Autism Spectrum Disorder (ASD) and other

PXMD

2 minute read

FOXO Technologies Inc. Announces 1-For-10 Reverse Stock Split; Will Become Effective At 4:01 p.m. ET On November 6, 2023

By Benzinga Newsdesk

October 27, 5:32 PM

FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company"), a leader in the field of commercializing epigenetic biomarker technology,today announced that its Board of Directors has approved a 1-for-10 reverse stock

FOXO

2 minute read

On October 25, VirnetX Filed A Certificate Of Amendment To The Co’s Amended And Restated Certificate Of Incorporation With The Secretary Of State Of The State Of Delaware To Effect A 1-For-20 Reverse Stock Split, To Trade On Adjusted Basis On October 2…

By Benzinga Newsdesk

October 26, 2:58 PM

On October 25, 2023, VirnetX Holding Corporation (the "Company") filed a certificate of amendment to the Company's Amended and Restated Certificate of Incorporation (the "Charter Amendment") with the Secretary of State

VHC

1 minute read

Smart for Life Announces 1-For-3 Reverse Stock Split

By Benzinga Newsdesk

October 26, 1:01 PM

Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, announced

SMFL

2 minute read

ZIVO Bioscience Announces 1-For-6 Reverse Stock Split

By Benzinga Newsdesk

October 26, 8:37 AM

Zivo Bioscience, Inc. (NASDAQ:ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced that

ZIVO

1 minute read

Addex Therapeutics Announces 1-for-20 Reverse ADS Split to Regain Nasdaq Compliance

By Benzinga Newsdesk

October 20, 3:12 AM

Addex Therapeutics (NASDAQ:ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that the Company's previously disclosed change to

ADXN

2 minute read

Mullen Automotive Files Preliminary Proxy Statement To The SEC To Hold A Stockholders Meeting On Dec 15, To Effect A Reverse Stock Split Of The Company’s Common Stock At An Exchange Ratio Between 1-For-2 To 1-For-100

By Benzinga Newsdesk

October 19, 8:33 AM

Mullen Automotive Inc. (Nasdaq: MULN) ("Mullen" or the "Company"), an emerging electric vehicle ("EV") manufacturer, announces today the Company has filed a preliminary proxy statement with the Securities and Exchange

MULN

2 minute read

NexImmune Announces 1-For-25 Reverse Stock Split

By Benzinga Newsdesk

October 18, 11:30 AM

NexImmune, Inc. (NASDAQ:NEXI) (the "Company") a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells

NEXI

2 minute read

JE Cleantech Holdings Limited Announces Share Consolidation 1-For-3 Reverse Stock Split To Regain NASDAQ Compliance

By Benzinga Newsdesk

October 13, 1:15 PM

JE Cleantech Holdings Limited (NASDAQ:JCSE) announced today that it will effect a share consolidation ("Reverse Stock Split") of its Ordinary Shares at a ratio of 1-for-3, effective as of 11:59 pm on October 13,

JCSE

1 minute read

Volcon Announces 1-For-5 Reverse Stock Split, Will Open For Trading On The Nasdaq Capital Market On October 16, 2023 On A Post-Split Basis

By Benzinga Newsdesk

October 13, 9:30 AM

Volcon Inc. (NASDAQ:VLCN), ("Volcon" or the "Company"), the first all-electric, off-road powersports company, today announced that it filed an amendment to its amended and restated certificate of incorporation with the

VLCN